The Scientist November 2019

Introducing

ZooMAb

®

Recombinant Antibodies

Now Ready for Launch

Fuel your discoveries with next-generation anti-

bodies that consistently deliver exactly what you

need: high specificity and sensitivity, recombinant

reproducibility, and continuous access to more

predictable materials.

Our top cited antibodies are now even bet ter.

Explore with ZooMAb®

Recombinant Antibodies.

SigmaAldrich.com/ZooMAb

The life science business of Merck

KGaA, Darmstadt, Germany

operates as MilliporeSigma

in the U.S. and Canada.

© 2019 Merck KGaA, Darmstadt, Germany and/or its
affiliates. All Rights Reserved. MilliporeSigma, the vibrant
M, Sigma-Aldrich and ZooMAb are trademarks of Merck
KGaA, Darmstadt, Germany or its affiliates. All other
trademarks are the property of their respective owners.
Detailed information on trademarks is available via
publicly accessible resources. 2019-20172